Soft tissue repair sales will expand through 2036, with orthopaedics holding a 66.9% share in 2026 as the leading application segment. The market is expected to reach USD 7.98 billion in 2026 and USD 12.39 billion by 2036, creating an absolute dollar opportunity of USD 4.41 billion between 2026 and 2036.